Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Garcia Marino. Insider active across 1 company, notably Dianthus Therapeutics, Inc. /DE/. Aggregated, 11 reports have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €15.6m. History available since 12 March 2026. The latest transaction was filed on 7 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Garcia Marino
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
40,000 shares@ US$8.440.0054% mcap1.6% of flowCommon StockSEC:0001669866-26-000010:0
126,000 shares@ US$8.440.017% mcap5.2% of flowCommon StockSEC:0001669866-26-000010:1
23,907 shares@ US$108.050.041% mcap12.6% of flowCommon StockSEC:0001669866-26-000010:3
2,373 shares@ US$109.100.0041% mcap1.3% of flowCommon StockSEC:0001669866-26-000010:4
2,536 shares@ US$110.020.0044% mcap1.4% of flowCommon StockSEC:0001669866-26-000010:5
800 shares@ US$110.760.0014% mcap0.4% of flowCommon StockSEC:0001669866-26-000010:6
104,091 shares@ US$107.960.18% mcap54.6% of flowCommon StockSEC:0001669866-26-000010:7
21,909 shares@ US$108.720.038% mcap11.6% of flowCommon StockSEC:0001669866-26-000010:8
10,384 shares@ US$107.490.018% mcap5.4% of flowCommon StockSEC:0001669866-26-000010:2
59,700 shares@ US$6.70100.0% of flowCommon StockSEC:0001669866-26-000007:0
122,918 shares@ US$6.7067.1% of flowCommon StockSEC:0001669866-26-000005:0
About Garcia Marino
Garcia Marino is CEO AND PRESIDENT at Dianthus Therapeutics, Inc. /DE/ (XNAS). He has made 11 filings in total, and across the sampled recent filings from 2026-03-13 to 2026-08-07, the sell amount is EUR 15571269, with the dominant transaction nature listed as Cession.